A. Shah

Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years.

G. Stone, A. Lansky, D. Kereiakes, 2013, The American journal of cardiology.